Medicine and Dentistry
Adjuvant Chemotherapy
19%
Analysis
40%
Anaplastic Lymphoma Kinase
24%
Biological Marker
45%
Biopsy Technique
21%
Cancer Registry
15%
Capsid Protein L1
21%
Case Report
14%
Cells
18%
Chronic Graft Versus Host Disease
21%
Colon
20%
Combination Therapy
15%
Diagnosis
23%
Echography
23%
Elderly Patient
13%
Epidermal Growth Factor Receptor
80%
Epidermal Growth Factor Receptor
14%
Gene Mutation
18%
Human Papillomavirus Type 16
17%
Immunohistochemistry
21%
Immunoreactivity
17%
Inpatient
25%
Lung
53%
Lung Adenocarcinoma
23%
Lung Cancer
91%
Malignant Neoplasm
21%
Malignant Pleural Effusion
17%
MALT Lymphoma
17%
Metastatic Carcinoma
17%
Neoplasm
100%
Next Generation Sequencing
13%
Non Small Cell Lung Cancer
59%
Overall Survival
32%
Pathologist
25%
Pathology
22%
Patient
59%
Phosphodiesterase IV Inhibitor
13%
Pneumonectomy
13%
Prevalence
16%
Prognostic Factor
35%
Promoter Region
17%
Prostate Cancer
30%
Protein Expression
20%
Recurrent Disease
20%
Sonic Hedgehog Protein
14%
Squamous Cell Carcinoma
27%
Thyroid Gland
20%
Tyrosine-Kinase Inhibitor
21%
Uterine Cervix Cytology
21%
Wart Virus
33%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lung Injury
8%
Acute Lung Injury
8%
Amosite
5%
Anaplastic Lymphoma Kinase
19%
Asparaginase
6%
Biological Marker
11%
Bleomycin
8%
Bleomycin
8%
Cardiotoxicity
8%
Chrysotile
10%
Crocidolite
5%
Cyclooxygenase 2
6%
Doxorubicin
8%
Epidermal Growth Factor Receptor
36%
Epithelium Tumor
8%
Fluorouracil
8%
Folinic Acid
8%
Gleason Score
8%
Head and Neck Cancer
8%
Hedgehog
8%
High-Throughput Screening
6%
Imatinib
8%
Imatinib
8%
Immunotherapy
6%
Lung Cancer
49%
Lung Fibrosis
9%
Lung Fibrosis
9%
Malignant Pleura Effusion
8%
Messenger RNA
6%
Metastatic Colon Cancer
8%
Microparticle
8%
Mouse
7%
Nasopharynx Carcinoma
8%
Neoplasm
39%
Neoplasm
11%
Non Small Cell Lung Cancer
36%
Non Small Cell Lung Cancer
13%
Overall Survival
16%
Oxaliplatin
13%
Pravastatin
8%
Programmed Death-Ligand 1
8%
Progression Free Survival
7%
Prospective Study
6%
Prostate Cancer
17%
Protein Tyrosine Kinase Inhibitor
17%
Rabbit Model
8%
Rat Model
8%
Sonic Hedgehog Protein
7%
Tumor Lysis Syndrome
8%
Vasculotropin
8%
Biochemistry, Genetics and Molecular Biology
Anaplastic Lymphoma Kinase
21%
Anaplastic Lymphoma Kinase
8%
Anticancer
6%
Biomarker Validation
8%
Cancer Cell
19%
Cancer Specific Survival
8%
Cell Survival
6%
Centromere
8%
Chromosome 8
8%
Cyclooxygenase
6%
Demethylation
9%
Disease Free Survival
17%
Electric Potential
6%
Enhancer Region
6%
Epidermal Growth Factor Receptor
40%
Epigenetics
10%
Exome Sequencing
8%
FGF9
8%
Fluorescence in Situ Hybridization
17%
Fluorescence in Situ Hybridization
12%
Gene Amplification
10%
Gene Mutation
15%
Genotyping
10%
Hepatocyte
5%
KRAS
9%
Membrane
5%
Mesenchymal-Epithelial Transition
11%
Messenger RNA
5%
Methylation
6%
Mutation
17%
Nested Gene
5%
Next Generation Sequencing
17%
Overall Survival
10%
PD-L1
17%
Phlorotannin
8%
Prevalence
5%
Prevalence
5%
Promoter Region
5%
Protein Expression
5%
Rat Model
8%
ROS1
11%
Screening
5%
Sirtuin1
8%
SOX2
13%
Spatial Omics
8%
Tissue Microarray
11%
Transdifferentiation
8%
Tyrosine Kinase Inhibitor
10%
Upregulation
10%
Vascular Endothelial Growth Factor
8%
